Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat hypercholesterolemia, is associated with a better disease outcome. Whether statins directly affect virus replication or influence the clinical outcome through modulation of immune responses is unknown. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapatero-Belinchón, Francisco J., Moeller, Rebecca, Lasswitz, Lisa, van Ham, Marco, Becker, Miriam, Brogden, Graham, Rosendal, Ebba, Bi, Wenjie, Carriquí-Madroñal, Belén, Islam, Koushikul, Lenman, Annasara, Gunesch, Antonia P., Kirui, Jared, Pietschmann, Thomas, Överby, Anna K., Jänsch, Lothar, Gerold, Gisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599137/
https://www.ncbi.nlm.nih.gov/pubmed/34812415
http://dx.doi.org/10.1016/j.isci.2021.103469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599137/
https://www.ncbi.nlm.nih.gov/pubmed/34812415
http://dx.doi.org/10.1016/j.isci.2021.103469

Ejemplares similares